BIOTECHNOLOGY INSTRUMENTS MARKET ANALYSIS

Regional Analysis

Global Biotechnology Instruments Market: Regional Insights

Based on geography, the global biotechnology instruments market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period due to the rising prevalence of target diseases, growing geriatric population, high adoption of point-of-care diagnostic tests/devices, and increasing demand for IVD instruments in the region. For instance, in November 2021, Thermo Fisher Scientific announced the launch of the new IVD system called Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR. The system is designed to support IVD testing and the development of assay menus. This in turn is expected to propel the growth of the biotechnology instruments market in the region.

Europe and Asia Pacific are also expected to witness robust growth in the global biotechnology instruments market due to the rise in burden of target diseases, growing geriatric population, high demand for IVD instruments, increasing adoption of point-of-care diagnostic tests/devices in these regions. For instance, in May 2022, Agilent Technologies launched CE-IVD marked instruments, kits, and reagents as IVDR Class A, in compliance with the new EU IVDR regulation. This launch ensures that labs in the EU who rely on Agilent IVDR instruments in their diagnostic workflows will continue to be able to use these products without disruption.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa